Bausch Health Cos EPS - Earnings per Share 2012-2026 | BHC
Bausch Health Cos eps - earnings per share from 2012 to 2026. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Bausch Health Cos Annual EPS | |
|---|---|
| 2025 | $0.42 |
| 2024 | $-0.13 |
| 2023 | $-1.62 |
| 2022 | $-0.62 |
| 2021 | $-2.64 |
| 2020 | $-1.58 |
| 2019 | $-5.08 |
| 2018 | $-11.81 |
| 2017 | $6.83 |
| 2016 | $-6.94 |
| 2015 | $-0.85 |
| 2014 | $2.58 |
| 2013 | $-2.70 |
| 2012 | $-0.38 |
| 2011 | $0.49 |
| Bausch Health Cos Quarterly EPS | |
|---|---|
| 2026-03-31 | $-3.82 |
| 2025-12-31 | $-0.30 |
| 2025-09-30 | $0.48 |
| 2025-06-30 | $0.40 |
| 2025-03-31 | $-0.16 |
| 2024-12-31 | $0.24 |
| 2024-09-30 | $-0.23 |
| 2024-06-30 | $0.03 |
| 2024-03-31 | $-0.17 |
| 2023-12-31 | $-0.11 |
| 2023-09-30 | $-1.03 |
| 2023-06-30 | $0.07 |
| 2023-03-31 | $-0.55 |
| 2022-12-31 | $-1.13 |
| 2022-09-30 | $1.10 |
| 2022-06-30 | $-0.40 |
| 2022-03-31 | $-0.19 |
| 2021-12-31 | $0.21 |
| 2021-09-30 | $0.52 |
| 2021-06-30 | $-1.66 |
| 2021-03-31 | $-1.71 |
| 2020-12-31 | $-0.43 |
| 2020-09-30 | $0.20 |
| 2020-06-30 | $-0.92 |
| 2020-03-31 | $-0.43 |
| 2019-12-31 | $-4.30 |
| 2019-09-30 | $-0.14 |
| 2019-06-30 | $-0.49 |
| 2019-03-31 | $-0.15 |
| 2018-12-31 | $-0.96 |
| 2018-09-30 | $-1.00 |
| 2018-06-30 | $-2.49 |
| 2018-03-31 | $-7.36 |
| 2017-12-31 | $1.46 |
| 2017-09-30 | $3.69 |
| 2017-06-30 | $-0.11 |
| 2017-03-31 | $1.79 |
| 2016-12-31 | $-1.49 |
| 2016-09-30 | $-3.49 |
| 2016-06-30 | $-0.88 |
| 2016-03-31 | $-1.08 |
| 2015-12-31 | $-1.12 |
| 2015-09-30 | $0.14 |
| 2015-06-30 | $-0.15 |
| 2015-03-31 | $0.28 |
| 2014-12-31 | $1.47 |
| 2014-09-30 | $0.81 |
| 2014-06-30 | $0.37 |
| 2014-03-31 | $-0.07 |
| 2013-12-31 | $0.28 |
| 2013-09-30 | $-2.92 |
| 2013-06-30 | $0.03 |
| 2013-03-31 | $-0.09 |
| 2012-12-31 | $-0.29 |
| 2012-09-30 | $0.02 |
| 2012-06-30 | $-0.07 |
| 2012-03-31 | $-0.04 |
| 2011-12-31 | $0.17 |
| 2011-09-30 | $0.13 |
| 2011-06-30 | $0.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |